THERAPEUTIC AGAINST DISEASES ASSOCIATED WITH THE DEATH OF THE CELLS OF THE ENDOTHELIUM OF THE CORNITUM, DUE TO THE CONDITION OF THE ENDOPLASMATIC RETICULUM

• 收藏
• 分享

专利权人:

СЭНДЗЮ ФАРМАСЬЮТИКАЛ КО., ЛТД. (JP);КИОТО ПРИФЕКЧУРАЛ ПАБЛИК ЮНИВЕРСИТИ КОРПОРЭЙШН (JP);ДЗЕ ДОСИСА (JP)

发明人:

КОИЗУМИ Норико (JP),ОКУМУРА Наоки (JP),КИНОСИТА Сигеру (JP)

申请号：

RU2016121150

公开号：

RU2016121150A

申请日:

2014.10.30

申请国别(地区):

RU

年份:

2017

代理人:

摘要：

The present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress. Specifically, the present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress in the corneal epithelium, the drug containing a TGF²-signal inhibitor. As a preferred TGF²-signal inhibitor, the drug contains 4-[4-(1,3-benzodioxole-5-yl)-5-(2-pyridinyl)-1H-imidazole-2-yl]benzamide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/